Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer

NCT06807398 · clinicaltrials.gov ↗

COMPLETED

Status

367

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)

Interventions

GENETIC: Data will be used to develop a novel predictive model assessing the risk of LNI.

Sponsor

Francesco Montorsi

Collaborators

Ministero della Salute, Italy